What could marijuana drug reclassification mean for Chicago cannabis companies?

August 21, 2025

The Trump administration is considering softening the classification of marijuana, from a Schedule I to a Schedule III drug. And this could have major implications for cannabis businesses in Chicago.

Reset sits down with local cannabis industry and business leaders to understand how this reclassification could impact the local industry and what it could mean for consumers.

GUESTS: Tiffany Ingram, executive director of the Cannabis Business Association of Illinois

Jonah Rapino, director of marketing at nuEra in Lincoln Park

Akele Parnell, co-founder of Ümi Dispensary in Lincoln Park

 

Search

RECENT PRESS RELEASES